Retinal Vascular Reactivity in Type 1 Diabetes Patients Without Retinopathy Using Optical Coherence Tomography Angiography.
Adolescent
Adult
Child
Child, Preschool
Diabetes Mellitus, Type 1
/ complications
Diabetic Retinopathy
/ diagnosis
Female
Fluorescein Angiography
/ methods
Fundus Oculi
Humans
Male
Retinal Vessels
/ diagnostic imaging
Tomography, Optical Coherence
/ methods
Vascular Resistance
/ physiology
Young Adult
Journal
Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701
Informations de publication
Date de publication:
03 06 2020
03 06 2020
Historique:
entrez:
24
6
2020
pubmed:
24
6
2020
medline:
8
1
2021
Statut:
ppublish
Résumé
We hypothesize that patients with type 1 diabetes (T1D) may have abnormal retinal vascular responses before diabetic retinopathy (DR) is clinically evident. Optical coherence tomography angiography (OCTA) was used to dynamically assess the retinal microvasculature of diabetic patients with no clinically visible retinopathy. Controlled nonrandomized interventional study. The studied population included 48 eyes of 24 T1D patients and 24 demographically similar healthy volunteers. A commercial OCTA device (AngioVue) was used, and two tests were applied: (1) the hypoxia challenge test (HCT) and (2) the handgrip test to induce a vasodilatory or vasoconstrictive response, respectively. The HCT is a standardized test that creates a mild hypoxic environment equivalent to a flight cabin. The handgrip test (i.e., isometric exercise) induces a sympathetic autonomic response. Changes in the parafoveal superficial and deep capillary plexuses in both tests were compared in each group. Systemic cardiovascular responses were also comparatively evaluated. In the control cohort, the vessel density of the median parafoveal superficial and deep plexuses increased during hypoxia (F1,23 = 15.69, P < 0.001 and F1,23 = 16.26, P < 0.001, respectively). In the T1D group, this physiological response was not observed in either the superficial or the deep retinal plexuses. Isometric exercise elicited a significant decrease in vessel density in both superficial and deep plexuses in the control group (F1,23 = 27.37, P < 0.0001 and F1,23 = 27.90, P < 0.0001, respectively). In the T1D group, this response was noted only in the deep plexus (F1,23 = 11.04, P < 0.01). Our work suggests there is an early impairment of the physiological retinal vascular response in patients with T1D without clinical diabetic retinopathy.
Identifiants
pubmed: 32574352
pii: 2770173
doi: 10.1167/iovs.61.6.49
pmc: PMC7415313
doi:
Types de publication
Controlled Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
49Références
Acta Ophthalmol. 2009 Nov;87(8):875-80
pubmed: 18976308
Surv Ophthalmol. 2018 Sep - Oct;63(5):646-664
pubmed: 29577954
Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5548-5555
pubmed: 29075766
JAMA Ophthalmol. 2018 Nov 1;136(11):1242-1248
pubmed: 30352114
Sci Rep. 2019 Jun 17;9(1):8668
pubmed: 31209251
Clin Pharmacol Ther. 2009 Nov;86(5):527-32
pubmed: 19641491
Br J Ophthalmol. 2015 Jan;99(1):64-8
pubmed: 25091950
Diabetes Res Clin Pract. 2019 Jul;153:1-5
pubmed: 31145928
Br J Clin Pharmacol. 2004 Jun;57(6):695-713
pubmed: 15151515
Surv Ophthalmol. 2018 Sep - Oct;63(5):601-608
pubmed: 29679616
J Clin Med. 2019 Sep 08;8(9):
pubmed: 31500344
BMJ Open Diabetes Res Care. 2015 Feb 17;3(1):e000044
pubmed: 25713725
Acta Ophthalmol. 2017 Dec;95(8):e751-e755
pubmed: 28211261
Prog Retin Eye Res. 2008 May;27(3):284-330
pubmed: 18448380
Front Neurosci. 2019 Jun 12;13:566
pubmed: 31249500
Cardiovasc Res. 2010 Feb 1;85(3):560-70
pubmed: 19734167
Invest Ophthalmol Vis Sci. 2019 Mar 1;60(4):990-998
pubmed: 30884528
Am J Physiol Heart Circ Physiol. 2017 Feb 1;312(2):H201-H212
pubmed: 27923786
Invest Ophthalmol Vis Sci. 2018 Aug 1;59(10):4115-4122
pubmed: 30098201
J Caffeine Res. 2012 Jun;2(2):70-76
pubmed: 24761267
PLoS One. 2019 Apr 2;14(4):e0214685
pubmed: 30939178
Prog Retin Eye Res. 2019 May;70:1-22
pubmed: 30999027
Diabetes Care. 1985 Sep-Oct;8(5):491-8
pubmed: 4053936
Retina. 2015 Nov;35(11):2364-70
pubmed: 26469537
Invest Ophthalmol Vis Sci. 2019 Jun 3;60(7):2468-2473
pubmed: 31173077
Eye (Lond). 2020 Feb;34(2):307-311
pubmed: 31273312
Hypertens Res. 2011 Aug;34(8):929-34
pubmed: 21614005
Invest Ophthalmol Vis Sci. 2006 Apr;47(4):1612-9
pubmed: 16565400
Ophthalmology. 2019 Dec;126(12):1675-1684
pubmed: 31358386
Invest Ophthalmol Vis Sci. 2019 Apr 1;60(5):1412-1419
pubmed: 30943289
Br J Ophthalmol. 2017 Jan;101(1):16-20
pubmed: 27707691
Invest Ophthalmol Vis Sci. 1986 May;27(5):722-6
pubmed: 3700021
Graefes Arch Clin Exp Ophthalmol. 1999 Apr;237(4):296-300
pubmed: 10208262
Invest Ophthalmol Vis Sci. 2012 Jun 28;53(7):4299-305
pubmed: 22661466
Invest Ophthalmol Vis Sci. 2017 May 1;58(5):2449-2455
pubmed: 28460046
Anat Rec (Hoboken). 2019 Dec 19;:
pubmed: 31854073
Invest Ophthalmol Vis Sci. 2016 Apr;57(4):1523-9
pubmed: 27035625
Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):190-196
pubmed: 28114579
Invest Ophthalmol Vis Sci. 2013 Jan 30;54(1):842-7
pubmed: 23307962
Am J Ophthalmol. 2017 Apr;176:15-25
pubmed: 28057456
Endocr Rev. 2007 Aug;28(5):463-91
pubmed: 17525361
Cardiovasc Res. 2001 Feb 1;49(2):281-7
pubmed: 11164838
J Physiol. 2016 Feb 1;594(3):625-40
pubmed: 26607393
Am Rev Respir Dis. 1993 Nov;148(5):1215-9
pubmed: 8239156
Ophthalmol Retina. 2017 Jul - Aug;1(4):261-262
pubmed: 31047506
J Neural Eng. 2019 Jun;16(3):036024
pubmed: 30917357
Diabetes Care. 2016 Sep;39(9):1643-9
pubmed: 27555623
Prog Retin Eye Res. 2018 May;64:1-55
pubmed: 29229445
World J Diabetes. 2015 Apr 15;6(3):489-99
pubmed: 25897358
Acta Ophthalmol. 2018 May;96(3):e315-e319
pubmed: 29160042
JAMA Ophthalmol. 2017 Apr 1;135(4):370-376
pubmed: 28301651
Br J Ophthalmol. 2019 Dec;103(12):1747-1752
pubmed: 30674454
Acta Diabetol. 2017 Jul;54(7):695-702
pubmed: 28474119
Acta Ophthalmol. 2010 Jun;88(4):453-7
pubmed: 19681793
Acta Diabetol. 2018 May;55(5):469-477
pubmed: 29453673
Microvasc Res. 2001 Sep;62(2):143-53
pubmed: 11516243
Mult Scler. 2019 Feb;25(2):224-234
pubmed: 29303033